Nectin-4 overexpression has been reported in ductal breast carcinoma, lung adenocarcinoma, and pancreatic cancer; and high Nectin-4 expression in those tumors was associated with disease progression or poor prognosis [22–26]. The gene discussed is NECTIN4; the disease is lung adenocarcinoma.